Australia markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
194.11-0.27 (-0.14%)
At close: 04:00PM EDT
194.99 +0.88 (+0.45%)
After hours: 05:33PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
1,161,100
1,161,100
3,046,900
1,556,100
4,000,600
Depreciation & amortisation
494,800
494,800
518,400
487,700
457,200
Deferred income taxes
-305,800
-305,800
-168,600
-426,800
149,000
Stock-based compensation
264,200
264,200
254,100
238,600
198,300
Change in working capital
-648,700
-648,700
-890,300
-145,500
-187,200
Accounts receivable
61,300
61,300
-203,400
324,800
2,800
Inventory
-130,900
-130,900
-320,200
-462,400
-316,300
Other working capital
1,235,800
1,235,800
1,141,100
3,345,000
3,678,000
Other non-cash items
304,100
304,100
335,300
337,100
119,900
Net cash provided by operating activities
1,547,200
1,547,200
1,384,300
3,639,900
4,229,800
Cash flows from investing activities
Investments in property, plant and equipment
-311,400
-311,400
-243,200
-294,900
-551,800
Acquisitions, net
-6,926,100
-6,926,100
0
0
-1,006,500
Purchases of investments
-5,140,700
-5,140,700
-3,448,500
-3,808,700
-6,397,700
Sales/maturities of investments
7,500,400
7,500,400
3,671,000
3,498,900
7,374,300
Other investing activities
-11,300
-11,300
24,400
12,900
-26,900
Net cash used for investing activities
-4,101,000
-4,101,000
1,576,600
-563,700
-608,600
Cash flows from financing activities
Debt repayment
-809,900
-809,900
-1,002,200
-170,000
-1,500,000
Common stock repurchased
0
0
-750,000
-1,800,000
-6,679,100
Other financing activities
6,300
6,300
6,800
-115,500
-56,400
Net cash used provided by (used for) financing activities
149,300
149,300
-1,747,300
-2,086,200
-5,272,700
Net change in cash
-2,404,500
-2,404,500
1,213,600
990,000
-1,651,500
Cash at beginning of period
3,419,300
3,419,300
2,261,400
1,331,200
2,913,700
Cash at end of period
1,049,900
1,049,900
3,419,300
2,261,400
1,331,200
Free cash flow
Operating cash flow
1,547,200
1,547,200
1,384,300
3,639,900
4,229,800
Capital expenditure
-311,400
-311,400
-243,200
-294,900
-551,800
Free cash flow
1,235,800
1,235,800
1,141,100
3,345,000
3,678,000